These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 18667139

  • 21. Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?
    Goldstein BJ.
    Int J Clin Pract; 2006 Jul; 60(7):873-83. PubMed ID: 16846404
    [Abstract] [Full Text] [Related]

  • 22. Minimizing the risk of hypoglycemia in older adults: a focus on long-term care.
    Garza H.
    Consult Pharm; 2009 Jun; 24 Suppl B():18-24. PubMed ID: 19555132
    [Abstract] [Full Text] [Related]

  • 23. Exploring the pharmacotherapeutic options for treating type 2 diabetes.
    Kruger DF.
    Diabetes Educ; 2008 Jun; 34 Suppl 3():60S-65S. PubMed ID: 18525066
    [Abstract] [Full Text] [Related]

  • 24. The role of inhaled insulin in the treatment of type 2 diabetes.
    Davis SN.
    J Diabetes Complications; 2008 Jun; 22(6):420-9. PubMed ID: 18413196
    [Abstract] [Full Text] [Related]

  • 25. Insulin therapy in type 2 diabetes.
    Davis T, Edelman SV.
    Med Clin North Am; 2004 Jul; 88(4):865-95, x. PubMed ID: 15308383
    [Abstract] [Full Text] [Related]

  • 26. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P.
    Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
    [Abstract] [Full Text] [Related]

  • 27. [Blood pressure and type 2 diabetes mellitus: impact of the insulin therapy].
    Dakhli S, Lamine S, Lamine F, Trabelsi N, Aouididi F, Zouaoui C, Mami FB, Achour A.
    Tunis Med; 2007 Nov; 85(11):945-50. PubMed ID: 19166146
    [Abstract] [Full Text] [Related]

  • 28. Initial combination therapy for type 2 diabetes mellitus: is it ready for prime time?
    Zinman B.
    Am J Med; 2011 Jan; 124(1 Suppl):S19-34. PubMed ID: 21194577
    [Abstract] [Full Text] [Related]

  • 29. [Hypoglycemic treatment of type 2 diabetes].
    Thorsby P, Kilhovd B, Sletmo R, Martinsen S, Birkeland KI.
    Tidsskr Nor Laegeforen; 2000 Aug 30; 120(20):2434-40. PubMed ID: 11475233
    [Abstract] [Full Text] [Related]

  • 30. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW.
    J Am Osteopath Assoc; 2007 Jul 30; 107(7):260-9. PubMed ID: 17682113
    [Abstract] [Full Text] [Related]

  • 31. A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes.
    Ribbing J, Hamrén B, Svensson MK, Karlsson MO.
    J Clin Pharmacol; 2010 Aug 30; 50(8):861-72. PubMed ID: 20484615
    [Abstract] [Full Text] [Related]

  • 32. Addressing insulin resistance in Type 1 diabetes.
    Pang TT, Narendran P.
    Diabet Med; 2008 Sep 30; 25(9):1015-24. PubMed ID: 19183305
    [Abstract] [Full Text] [Related]

  • 33. Current treatment approaches to type 2 diabetes mellitus: successes and shortcomings.
    Collins FM.
    Am J Manag Care; 2002 Oct 30; 8(16 Suppl):S460-71. PubMed ID: 12408409
    [Abstract] [Full Text] [Related]

  • 34. New-onset diabetes after liver transplantation: from pathogenesis to management.
    Marchetti P.
    Liver Transpl; 2005 Jun 30; 11(6):612-20. PubMed ID: 15915488
    [Abstract] [Full Text] [Related]

  • 35. Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes.
    Mao XM, Liu H, Tao XJ, Yin GP, Li Q, Wang SK.
    Diabetes Metab Res Rev; 2009 Jul 30; 25(5):435-41. PubMed ID: 19405039
    [Abstract] [Full Text] [Related]

  • 36. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 30; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 37. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR, Silva ME, Machado HA, Fukui RT, Correia MR, Santos RF, Wajchenberg BL, Rocha DM, Rondon MU, Negrão CE, Ursich MJ.
    Diabetes Obes Metab; 2008 Mar 30; 10(3):238-45. PubMed ID: 18269639
    [Abstract] [Full Text] [Related]

  • 38. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA, Kulkarni KD.
    J Am Diet Assoc; 2008 Apr 30; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [Abstract] [Full Text] [Related]

  • 39. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug 02; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract] [Full Text] [Related]

  • 40. Insulin and type 2 diabetes. Last resort or rational management?
    Holmwood C, Philips P.
    Aust Fam Physician; 1999 May 02; 28(5):429-35. PubMed ID: 10376366
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.